Oncolytics Biotech® Inc. Announces Participation in World Immunotherapy Congress USA 2017 – PR Newswire (press release)
|
Oncolytics Biotech® Inc. Announces Participation in World Immunotherapy Congress USA 2017
PR Newswire (press release) CALGARY, May 23, 2017 /PRNewswire/ – Oncolytics Biotech Inc. (TSX:ONC) (OTCQX:ONCYF) (Oncolytics or the Company) today announced that Dr. Andres A. Gutierrez, Chief Medical Officer of Oncolytics Biotech Inc. will present at the World Immunotherapy … |
